539997 — Kwality Pharmaceuticals Balance Sheet
0.000.00%
- IN₹7.82bn
- IN₹8.75bn
- IN₹3.07bn
- 93
- 25
- 70
- 71
Annual balance sheet for Kwality Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48.8 | 102 | 130 | 73.6 | 59.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 617 | 783 | 943 | 820 | 1,271 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 890 | 1,059 | 2,278 | 2,072 | 2,427 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 427 | 594 | 1,039 | 1,348 | 1,391 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,327 | 1,663 | 3,406 | 3,536 | 3,942 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 678 | 783 | 1,395 | 1,259 | 1,519 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 867 | 1,051 | 1,594 | 1,531 | 1,700 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 460 | 612 | 1,811 | 2,005 | 2,242 |
Total Liabilities & Shareholders' Equity | 1,327 | 1,663 | 3,406 | 3,536 | 3,942 |
Total Common Shares Outstanding |